General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

v3.2.0.727
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2012 7,000,000      
Beginning balance, value at Dec. 31, 2012 $ 700 $ 143,447 $ (144,216) $ (69)
Shares issued pursuant to PhytoSPHERE acquisition, shares 5,825,000      
Shares issued pursuant to PhytoSPHERE acquisition, value $ 582 7,069,418   7,070,000
Shares issued for cash (net of expenses), shares 2,750,000      
Shares issued for cash (net of expenses), value $ 275 2,731,148   2,731,423
Restricted shares issued under employment agreement, shares 5,000      
Restricted shares issued under employment agreement, value $ 1 5,649   5,650
To record beneficial conversion feature of debt   800,000   800,000
Net loss     (2,300,196) (2,300,196)
Ending balance, shares at Dec. 31, 2013 15,580,000      
Ending balance, value at Dec. 31, 2013 $ 1,558 10,749,662 (2,444,412) 8,306,808
Shares issued pursuant to PhytoSPHERE acquisition, value       0
Shares issued for cash (net of expenses), shares 8,031,666      
Shares issued for cash (net of expenses), value $ 803 8,421,697   8,422,500
Shares issued for conversion of note from Roen Ventures, LLC, shares 10,000,000      
Shares issued for conversion of note from Roen Ventures, LLC, value $ 1,000 5,999,000   6,000,000
Shares issued pursuant to employment agreement, shares 7,500      
Shares issued pursuant to employment agreement, value   42,125   42,125
Shares received in exchange for sale of equity investment, shares (500,000)      
Shares received in exchange for sale of equity investment, value $ (50) (8,299,950)   (8,300,000)
Stock-based compensation, shares 300,000      
Stock-based compensation, value $ 30 7,915,803   7,915,833
Net loss     (1,311,951) (1,311,951)
Ending balance, shares at Dec. 31, 2014 33,419,166      
Ending balance, value at Dec. 31, 2014 $ 3,341 24,828,337 (3,756,363) 21,075,315
Shares issued pursuant to PhytoSPHERE acquisition, value       0
Shares issued for cash (net of expenses), shares 1,260,000      
Shares issued for cash (net of expenses), value $ 126 2,519,874   2,520,000
Shares issued pursuant to underwriting services, shares 30,000      
Shares issued pursuant to underwriting services, value $ 3 87,597   87,600
Stock-based compensation, shares 250,000      
Stock-based compensation, value $ 25 1,755,969   1,755,994
Net loss     (2,648,809) (2,648,809)
Ending balance, shares at Mar. 31, 2015 34,959,166      
Ending balance, value at Mar. 31, 2015 $ 3,495 $ 29,191,777 $ (6,405,172) $ 22,790,100